ArticleCureus2026
Biopsy-Proven Non-glomerular Renal Pathology in Localized Granulomatosis With Polyangiitis Treated With Methotrexate and Avacopan Presenting With New Renal Symptoms: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis that commonly involves the upper respiratory tract and kidneys. The development of new-onset urinary abnormalities, microscopic hematuria, and declining renal function in a patient on treatment with methotrexate and avacopan warrants a prompt renal biopsy to lead management decisions. We describe a case of localized sinonasal GPA in a patient receiving methotrexate and avacopan who presented with new renal symptoms. Laboratory evaluation revealed a serum creatinine of 1.4 mg/dL and a urine protein-creatinine ratio (UPCR) of 0.96 g/g with moderate hematuria and red blood cell casts on urine microscopy. Renal biopsy revealed no evidence of pauci-immune crescentic glomerulonephritis, highlighting the importance of histopathologic confirmation before escalation of immunosuppressive therapy. These findings prevented escalation to stronger immunosuppressive therapy and allowed continuation of the existing regimen. Moreover, the combined use of methotrexate and avacopan in nasal-limited GPA is not well documented, and this case adds more clinical understanding to this therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.